Jean‐Baptiste Julla

High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold

Laurent Castéra, Cédric Laouenan, Anaïs Vallet‐Pichard et al. · Diabetes Care · 2023 · 123 citations · Full text

Medicine, Internal Medicine, Pathology +17

Glucagon-like Peptide 1 Receptor Agonists, Diabetic Retinopathy and Angiogenesis: The AngioSafe Type 2 Diabetes Study

Bénédicte Gaborit, Jean‐Baptiste Julla, Samaher Besbes et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 91 citations · Full text

Medicine, Endocrinology, Ophthalmology +17

Interplay between Liver X Receptor and Hypoxia Inducible Factor 1α Potentiates Interleukin-1β Production in Human Macrophages

Louise Ménégaut, Charles Thomas, Antoine Jalil et al. · Cell Reports · 2020 · 61 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID‐19 in type 2 diabetes

Fawaz Alzaïd, Jean‐Baptiste Julla, Marc Diedisheim et al. · EMBO Molecular Medicine · 2020 · 59 citations · Full text

Life Sciences, Immunology, Pathology +17

Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study

Marc Diedisheim, Catherine Pecquet, Jean‐Baptiste Julla et al. · Diabetes Technology & Therapeutics · 2023 · 30 citations

Medicine, Dermatology, Endocrinology +16